Trial Profile
A randomized, open-label study evaluating the effects of food and dosing regimen on Q-122 pharmacokinetics in healthy female volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Jun 2018
Price :
$35
*
At a glance
- Drugs Q 122 (Primary)
- Indications Hot flashes; Vasomotor symptoms
- Focus Pharmacokinetics
- Sponsors QUE Oncology
- 05 Jun 2018 Status changed from not yet recruiting to completed.
- 08 Nov 2017 New trial record